About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Tender Loving Care for Recurrent Pregnancy Loss | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT06182878

Tender Loving Care for Recurrent Pregnancy Loss

The goal of this investigational study is to evaluate participation in a weekly, interactive, tender loving care messaging platform impact on pregnancy outcomes in patients with recurrent pregnancy lo...

Lead sponsor: Walter Reed National Military Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

David Boedeker, DO

CONTACT

301-400-2140 david.h.boedeker.mil@health.mil

Kiley Hunkler, MD

CONTACT

301-400-2140 kiley.f.hunkler.mil@health.mil

Sponsors

Lead Sponsor

Walter Reed National Military Medical Center

Participants will be asked to interact with weekly messages providing prenatal counseling and support. Additionally, patients will be asked to complete the fertility quality of life survey several times over the course of the pregnancy.

Age

18 - 44 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Pregnant individuals receiving their prenatal care at WRNMMC
•Able to speak and understand English
•Less than or equal to 10+0 weeks gestation by last menstrual period (LMP) or dating ultrasound at the time of enrollment
•At least two prior pregnancy losses. Pregnancy losses must be confirmed with laboratory criteria confirming a positive pregnancy test in the military electronic medical record with subsequent resolution (resolution may be reported by patient), or with ultrasound criteria demonstrating an intrauterine gestational sac with subsequent resolution (resolution may be reported by patient).

Exclusion Criteria

•Age less than 18 years and older than 44 at time of enrollment
•Unable to speak or understand English
•Current smoker or tobacco use within 30 days
•History of uterine anomaly, coagulopathy, balanced translocation, endometrial polyps, submucosal fibroids, pathology confirmed acute or chronic endometritis, hydrosalpinx, history of Asherman syndrome, poorly controlled endocrinopathies, HIV infection
•History of gonadotoxic therapy or cancerous condition of the female reproductive tract
•Suspicion for or confirmation of an ectopic pregnancy

Related studies

High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety

NCT06968026 · Recurrent Pregnancy Loss, Anxiety Disorders

Genomics and Microbiome Investigation in Cases of Recurrent Pregnancy Losses

NCT06604338 · Recurrent Pregnancy Loss(RPL)

RECRUITINGPhase 4

Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages

NCT05725512 · Recurrent Miscarriage, Recurrent Pregnancy Loss, and more

Active Not RecruitingNA

Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss

NCT06007560 · Recurrent Pregnancy Loss

Not Yet RecruitingNA

Noninvasive Implantation Potential vs Morphology-Based Selection in IVF Single Blastocyst Transfer

NCT07461077 · Advanced Age, Recurrent Pregnancy Loss(RPL), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 1, 2024Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment60

Start dateJan 2024

Last updatedMay 1, 2024

Condition

Recurrent Pregnancy Loss

Locations shown

Walter Reed National Military Medical Center

Bethesda, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions